uniQure (NASDAQ:QURE) Receives Consensus Rating of Buy from Analysts

Shares of uniQure (NASDAQ:QURE – Get Free Report) have earned a consensus rating of “Buy” from the seven brokerages that are presently covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that have covered the stock in the last year is $45.30. […]

Related Keywords

,Ricardo Dolmetsch ,Financial Services Group Inc ,Coppell Advisory Solutions ,Goldman Sachs Group ,Roffman Miller Associates Inc ,Covestor Ltd ,Get Free Report ,Financial Advisors ,Services Group ,Miller Associates ,Get Free ,Qure Daily ,Uniqure ,Nasdaq Qure ,Qure ,Medical ,Ratings ,Consensus ,